Myriad Genetics reported $190.5M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Accelerate Diagnostics AXDX:US 16.21M 6.6M
Agilent A:US $ 1247M 51M
Becton, Dickinson and BDX:US $ 4359M 179M
Bio Rad Laboratories BIO:US $ 556.64M 69.15M
Biocept BIOC:US $ 22.65M 5.9M
Bruker BRKR:US $ 498.5M 59.6M
Danaher DHR:US $ 5516M 574M
Exact Sciences EXAS:US $ 663.56M 31.7M
Fluidigm FLDM:US 54.01M 4.47M
Hologic HOLX:US $ 841.6M 11.1M
Illumina ILMN:US $ 1.04B 119M
Johnson & Johnson JNJ:US $ 17.56B 2.4B
Mettler Toledo International MTD:US 684.79M 66.47M
Myriad Genetics MYGN:US $ 190.5M 13.4M
Nanostring Technologies NSTG:US $ 68.55M 1.25M
Orasure Technologies OSUR:US $ 83.68M 10.75M
Pacific Biosciences Of California PACB:US $ 110.7M 10M
Perkinelmer PKI:US $ 1004.6M 49.58M
Quest Diagnostics DGX:US $ 2098M 110M
Quidel QDEL:US $ 381.6M 121.46M
Repligen RGEN:US $ 146.4M 2.7M
Thermo Fisher Scientific TMO:US $ 8997M 66M
Veracyte VCYT:US $ 83.03M 3.36M
Waters WAT:US $ 495.1M 79.15M